Portfolio company
Bellco
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and manufactures extracorporeal blood filtration systems and dialysis equipment for patients with renal failure, organ failure and acute lung injury.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Quanta
The company develops portable hemodialysis systems for patients with renal failure across hospital, clinic and home care settings.
Trestle Biotherapeutics
This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.
NephroPlus
This company provides dialysis treatments and kidney care services to patients suffering from end-stage renal disease through a network of specialized clinics.
Outset Medical
Outset Medical manufactures a hemodialysis system for use by hospitals, health systems, skilled nursing facilities, and patients in their own homes.
Tengion Inc
This regenerative medicine company develops replacement organs and tissues using a patient's own cells for individuals with urologic, renal, gastrointestinal, and vascular diseases.
Bridge To Life
This company develops organ preservation solutions and machine perfusion systems for transplant centres and organ procurement organisations.
Hemotune
This company develops a magnetic blood purification platform using nanoengineered beads to remove specific disease-causing substances for patients with sepsis or requiring gene therapy.
React Health
React Health manufactures respiratory and sleep therapy equipment, such as ventilators and oxygen concentrators, for medical providers and patients with chronic breathing conditions.
